Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mott

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
The American Journal of Pathology|August 14, 2013
Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancerSinan Zhu, Ryan T Mott, Elizabeth A Fry, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Malaria-Infected Mice Are Cured by a Single Low Dose of a New Silylamide Trioxane Plus MefloquineLauren E Woodard, Bryan T Mott, Vandana Singhal, et al.
Assay and Drug Development Technologies|January 12, 2010
Comparison of bioluminescent kinase assays using substrate depletion and product formationCordelle Tanega, Min Shen, Bryan T Mott, et al.
Journal of Medicinal Chemistry|February 22, 2013
Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugsBryan T Mott, Abhai Tripathi, Maxime A Siegler, et al.
Journal of Neuroinflammation|September 29, 2006
Expression profiles for macrophage alternative activation genes in AD and in mouse models of ADCarol A Colton, Ryan T Mott, Hayley Sharpe, et al.
Plos One|September 10, 2011
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activitiesRan He, Bryan T Mott, Andrew S Rosenthal, et al.
Retrovirology|September 30, 2016
Drug resistant integrase mutants cause aberrant HIV integrationsJanani Varadarajan, Mary Jane McWilliams, Bryan T Mott, et al.
Journal of Neuro-Oncology|April 12, 2015
Anaplastic ganglioglioma: a report of three cases and review of the literatureJohn Thomas Lucas, Andrew Jonathan Huang, Ryan T Mott, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2009
Reduced ratio of afferent to total vascular density in mesial temporal sclerosisRyan T Mott, Clara R Thore, Dixon M Moody, et al.
Breast Cancer Research : BCR|October 28, 2025
Multi-receptor targeted therapy of breast cancer and brain metastases with a novel QUAD-drug conjugateWaldemar Debinski, Kaitlin N Fink, John Rossmeisl, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
The American Journal of Pathology|August 14, 2013
Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancerSinan Zhu, Ryan T Mott, Elizabeth A Fry, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Malaria-Infected Mice Are Cured by a Single Low Dose of a New Silylamide Trioxane Plus MefloquineLauren E Woodard, Bryan T Mott, Vandana Singhal, et al.
Assay and Drug Development Technologies|January 12, 2010
Comparison of bioluminescent kinase assays using substrate depletion and product formationCordelle Tanega, Min Shen, Bryan T Mott, et al.
Journal of Medicinal Chemistry|February 22, 2013
Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugsBryan T Mott, Abhai Tripathi, Maxime A Siegler, et al.
Journal of Neuroinflammation|September 29, 2006
Expression profiles for macrophage alternative activation genes in AD and in mouse models of ADCarol A Colton, Ryan T Mott, Hayley Sharpe, et al.
Plos One|September 10, 2011
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activitiesRan He, Bryan T Mott, Andrew S Rosenthal, et al.
Retrovirology|September 30, 2016
Drug resistant integrase mutants cause aberrant HIV integrationsJanani Varadarajan, Mary Jane McWilliams, Bryan T Mott, et al.
Journal of Neuro-Oncology|April 12, 2015
Anaplastic ganglioglioma: a report of three cases and review of the literatureJohn Thomas Lucas, Andrew Jonathan Huang, Ryan T Mott, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2009
Reduced ratio of afferent to total vascular density in mesial temporal sclerosisRyan T Mott, Clara R Thore, Dixon M Moody, et al.
Breast Cancer Research : BCR|October 28, 2025
Multi-receptor targeted therapy of breast cancer and brain metastases with a novel QUAD-drug conjugateWaldemar Debinski, Kaitlin N Fink, John Rossmeisl, et al.
Pageof 12